APA (7th ed.) Citation

CH, L., CW, C., SC, C., WY, K., WY, T., KI, C., . . . CH, W. (2025). Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma, 12, 2625. https://doi.org/10.2147/JHC.S560649

Chicago Style (17th ed.) Citation

CH, Lu, et al. "Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma." Journal of Hepatocellular Carcinoma 12 (2025): 2625. https://doi.org/10.2147/JHC.S560649.

MLA (9th ed.) Citation

CH, Lu, et al. "Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma." Journal of Hepatocellular Carcinoma, vol. 12, 2025, p. 2625, https://doi.org/10.2147/JHC.S560649.